Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, shared a post by Zara Baloch, Observer at HCA Houston Healthcare, on X, adding:
“Excited for the start of ASCO Breakthrough 2026 this week in Singapore. It is an honor to be selected as an ASCO Voice and to help share the science, discussions, and discoveries emerging from one of oncology’s premier global meetings.
Over the next several days, I look forward to covering key presentations, highlighting innovative research, and engaging with colleagues from around the world who are advancing cancer care through immunotherapy, cellular therapy, precision oncology, artificial intelligence, and translational research.
Thank you to ASCO for this opportunity, and to the investigators, clinicians, patients, and advocates whose work continues to move the field forward. Looking forward to an inspiring week of learning, collaboration, and innovation.”
Quoting Zara Baloch’s post:
“ASCO Breakthrough 2026 kicks off this week.
MedNewsWeek is bringing you the latest in cancer care from Singapore. Abstract breakdowns Expert highlights Breakthrough science June 25–27.
Follow along.”
Other articles about ASCO Breakthrough 2026 on OncoDaily.